Surgical Emergency Flows and Delays in Admission to the Operating Room

NCT04585529 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1149

Last updated 2021-05-26

No results posted yet for this study

Summary

French hospitals treat non-elective surgery according to three organizational models: in a dedicated multi-specialty emergency operative room (OR), in a dedicated OR within a specialized surgical platform or in any available OR from a list of non-dedicated OR. Some triage algorithms for the classification of non-elective surgery have been described but are not routinely applied. The rate of delay in the management of non-elective surgery in France is not known. Reducing this delay decreased mortality and morbidity in urgent surgery (McIsaac D, et al., CMAJ 2017). Optimizing the flow of non-elective surgery represents a major challenge. The main objective of this study is to determine the rate of delay in admission to the OR in emergency surgery through a multicenter prospective observational study in France. All patients requiring urgent surgical management (\<72 hours) will be included. The ideal time for surgery was previously defined by surgeons according to the NEST classification (NEST 1: within minutes; NEST 2: \< 1 hour; NEST 3: \< 4 hours; NEST 4: \< 12 hours; NEST 5: \< 48 hours; NEST 6: \< 72 hours). For each patient, the ratio between the observed time (actual Time To Surgery \[aTTS\] ) and the ideal time (ideal Time To Surgery \[iTTS\]) will be determined. The delay is identified by aTTS/iTTS ratio \>1.

Conditions

  • Surgery
  • Emergencies
  • Postoperative Complications

Sponsors & Collaborators

  • Société Française d'Anesthésie et de Réanimation

    collaborator OTHER
  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Delphine GARRIGUE, MD · University Hospital, Lille, France

  • Benoit TAVERNIER, MD, PhD · University Hospital, Lille, France

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-05
Primary Completion
2021-03-15
Completion
2021-03-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04585529 on ClinicalTrials.gov